SHINE Gets Conditional Commitment for $265M DOE Loan
SHINE has received a conditional commitment for a loan of $263 million from the U.S. Department of Energy’s (DOE) Office of Energy Dominance Financing, the company announced today. According to…
Tag Archives: SHINE Medical Technologies
SHINE, C-Ray Therapeutics Partner
SHINE Technologies has entered a supply agreement with C-Ray Therapeutics, a global radiopharmaceutical CRDMO, the company announced recently. According to a release, C-Ray will supply SHINE’s n.c.a. Lu-177 to Chinese…
SHINE Technologies Raises $240M
SHINE Technologies has raised $240 million in equity funding, the company announced recently. The round was led by NantWorks with additional participation from Fidelity Management & Research Company, Sumitomo Corporation of…
SHINE Acquires Lantheus’ SPECT Business
SHINE Technologies announced recently that it acquired Lantheus’ SPECT business, which includes the SPECT manufacturing facility in Massachusetts and its portfolio of diagnostic radiopharmaceuticals. “The nuclear medicine supply chain needs…
SHINE, Standard Nuclear to Partner
SHINE Technologies has entered into a strategic partnership with Standard Nuclear, a reactor-agnostic producer of TRISO nuclear fuel and radioisotope power systems, SHINE announced today. According to a release, the…
SHINE to Acquire Lantheus Portfolio
SHINE Technologies has entered into a definitive agreement to acquire the SPECT business from Lantheus, a radiopharmaceutical-focused company, the company announced recently. Lantheus’ SPECT product portfolio includes imaging agents for…
SHINE Expands Distribution to UAE
SHINE Technologies and Modawina Medical Company (MMC) have entered a strategic distribution partnership to bring Ilumira, SHINE’s non-carrier-added lutetium-177, to patients in the United Arab Emirates, the company announced recently….
SHINE Partners with Sumitomo to Access Asia
SHINE Technologies is partnering with Sumitomo Corporation of Americas (SCOA), a leading global trading and investment company, the company announced today. According to a release, the partnership, formalized through a…
SHINE to Supply UK Organization
SHINE Technologies has been selected to provide a 14 mega electron volt deuterium-tritium fusion system to the U.K. Atomic Energy Authority (UKAEA)’s Lithium Breeding Tritium Innovation (LIBRTI) program in 2027,…
SHINE, Antelope Surgical Solutions to Partner
SHINE Technologies has partnered with Antelope Surgical Solutions, a biotech company pioneering next-generation multimodal radiopharmaceuticals, the company announced recently. According to a release, the supply agreement will accelerate Antelope’s clinical…
